Received Jun 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 1 | 018B21A | IM / AR |
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 2 | 040B21A | IM / AR |
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 3 | 054A22A | IM / AR |
Gastrointestinal: Episodic discomfort/bloating/pain/unease without clear cause; chronic constipation (irregular bowel movements, difficulty passing stool); burning sensations in varying abdominal locations. Ocular: Persistent gritty/sandy feeling on both eyelids (dryness/irritation). Neurological/Sensory: Episodic neuropathy-like tingling, numbness, or pain (left rib area, shoulders, patchy); abnormal hot/cold sensations on skin (lower abdomen, lower back, shoulders, arms); burning sensations on skin (abdomen extending to other areas). Musculoskeletal: Disproportionate soreness/weakness after light lifting or minimal activity; recent soreness in paraspinal muscles along the spine; burning sensation in specific muscles from neck to shoulder (?coat-hanger? distribution). Fatigue/Malaise: General malaise; profound fatigue that worsens during flares; characteristic delayed/post-exertional malaise ? unable to perceive fatigue while active/moving, but intense crash upon resting or stopping. Sleep: Difficulty staying asleep (frequent awakenings); insomnia despite exhaustion; unrefreshing sleep due to nocturia (multiple nighttime bathroom trips). Symptoms are non-length-dependent and migratory, worsening overtime. Blood test, MRIs, CT scan all normal. Doctors (neurologist, ophthalmologist, rheumatologist, gastro) that I have seen don't know how to treat this.
none.
none.
B-complex, D3/k2, Vit - C, Vit E.
none.
Onset ~2021 with no known prior similar illness, allergies, or strong family history. Rheumatology evaluation: autoimmune conditions ?ruled out? on initial panels. Ophthalmology: gritty eyes treated symptomatically with warm compresses, eye drops, lid cleanser; no severe findings. Gastroenterology: normal findings; abdominal CT normal. No other major comorbidities reported. Nucleocapsid Ab negative (2026). Thoracic Spine MRI (without contrast, collected Feb 13, 2026): Mild multilevel degenerative changes primarily due to facet arthrosis causing multilevel mild neuroforaminal narrowing. No significant spinal canal narrowing. Benign hemangioma in central T10 vertebral body. Discs largely preserved with minimal desiccation at T12-L1. Brain MRI: Normal(2026). EMG/Nerve Conduction Studies (both legs): Normal ? rules out large-fiber neuropathy/radiculopathy. ANA: Positive, titer 1:80, speckled pattern 2026 (previously negative in prior year). ENA Panel: All negative (Ro52 <2.3 CU, Ro60 <4.9 CU, SS-B <3.3 CU, Sm <3.3 CU, RNP <3.5 CU, Scl-70 <1.2 CU, Jo-1 <2.2 CU, Centromere <3.4 CU). Complements: C3 96.2 mg/dL (normal 82?185), C4 25.6 mg/dL (normal 15?53). Anti-CCP: Normal/negative. SARS-CoV-2 Spike Antibody (Total, semi-quantitative): >2500.0 U/mL (HIGH) ? collected ~May 2026 (Quest). Reference <0.8 U/mL. Routine bloodwork, rheumatology, and allergy panels: Normal.